Gary W. Herschman, Anjana D. Patel, and Zachary S. Taylor, attorneys in the Health Care & Life Sciences practice, in the firm’s Newark office, were quoted in Bloomberg Health Law & Business, in “Investor Appetite for Health Deals ‘Insatiable’ as Omicron Looms,” by Christopher Brown.

Following is an excerpt:

Health-care dealmaking kept up a brisk pace in November, setting up what could be a blockbuster December and a record-breaking year, attorneys and analysts say.

The number of deals announced and closed in November reached 236, up from 223 in October and 213 in September, said Gary Herschman of Epstein, Becker & Green in Newark.

“Due to the volume of deals planning to close by year end, we expect that December activity will more than double November’s activity,” Herschman said.

Life sciences and pharmaceuticals again led all sectors with 48 deals, followed by physician services and practices (31), health-care information technology and software (30), medical devices (29), cannabis (24), behavioral health (13), and home health (10). …

Health IT in Demand

Activity in the health IT sector continued at a high level in November, as consumer demand increased for “no-touch solutions” in health care, said Anjana Patel of Epstein, Becker & Green.

“Companies know they need to innovate to meet the market’s demands and to remain competitive, and this has driven up the demand for infusions of capital from interested buyers,” she said. …

The cannabis sector saw 24 announced or closed deals in November, pushing the year-to-date total to 260 transactions, said Zachary Taylor of Epstein, Becker & Green.

The number of deals will likely increase in 2022 despite the lack of movement at the federal level towards regulatory changes, he said.

“Lenders seem to have become more comfortable with the prospects and future financial sustainability of cannabis businesses, which has translated in the availability of more financing,” he said. “And that, in turn, has increased interest from investors, leading to more deals and more consolidation as investors look to scale up to keep up with fierce competition.”

Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.